Determination of trace level genotoxic impurities in small molecule drug substances using conventional headspace gas chromatography with contemporary ionic liquid diluents and electron capture detection.

Ionic liquids (ILs) were used as a new class of diluents for the analysis of two classes of genotoxic impurities (GTIs), namely, alkyl/aryl halides and nitro-aromatics, in small molecule drug substances by headspace gas chromatography (HS-GC) coupled with electron capture detection (ECD). This novel approach using ILs as contemporary diluents greatly broadens the applicability of HS-GC for the determination of high boiling (≥ 130°C) analytes including GTIs with limits of detection (LOD) ranging from 5 to 500 parts-per-billion (ppb) of analytes in a drug substance. This represents up to tens of thousands-fold improvement compared to traditional HS-GC diluents such as dimethyl sulfoxide (DMSO) and dimethylacetamide (DMAC). Various ILs were screened to determine their suitability as diluents for the HS-GC/ECD analysis. Increasing the HS oven temperatures resulted in varying responses for alkyl/aryl halides and a significant increase in response for all nitroaromatic GTIs. Linear ranges of up to five orders of magnitude were found for a number of analytes. The technique was validated on two active pharmaceutical ingredients with excellent recovery. This simple and robust methodology offers a key advantage in the ease of method transfer from development laboratories to quality control environments since conventional validated chromatographic data systems and GC instruments can be used. For many analytes, it is a cost effective alternative to more complex trace analytical methodologies like LC/MS and GC/MS, and significantly reduces the training needed for operation.

[1]  C. Poole Derivatization reactions for use with the electron-capture detector. , 2013, Journal of chromatography. A.

[2]  David Q. Liu,et al.  Enhancing the detection sensitivity of trace analysis of pharmaceutical genotoxic impurities by chemical derivatization and coordination ion spray-mass spectrometry. , 2010, Journal of chromatography. A.

[3]  Andrew Teasdale,et al.  Genotoxic Impurities: Strategies for Identification and Control , 2011 .

[4]  K. Mukkanti,et al.  Low-Level Quantitation of Formaldehyde in Drug Substance by HPLC–UV , 2012, Chromatographia.

[5]  David Q. Liu,et al.  A generic approach for the determination of trace hydrazine in drug substances using in situ derivatization-headspace GC-MS. , 2009, Journal of pharmaceutical and biomedical analysis.

[6]  W. G. Mcintire A rationale for determining Louisiana's coastal zone , 1975 .

[7]  D. Kirkland,et al.  Assessment of the genotoxic and carcinogenic risks of p-nitrophenol when it is present as an impurity in a drug product. , 2009, Regulatory toxicology and pharmacology : RTP.

[8]  A. Krstulović,et al.  Determination of polar alkylating agents as thiocyanate/isothiocyanate derivatives by reaction headspace gas chromatography , 2003 .

[9]  Lutz Müller,et al.  A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity. , 2006, Regulatory toxicology and pharmacology : RTP.

[10]  H S Rosenkranz,et al.  Mutagenicity and genotoxicity of nitroarenes. All nitro-containing chemicals were not created equal. , 1983, Mutation research.

[11]  D. Elder,et al.  Control and analysis of alkyl and benzyl halides and other related reactive organohalides as potential genotoxic impurities in active pharmaceutical ingredients (APIs). , 2008, Journal of pharmaceutical and biomedical analysis.

[12]  David Q. Liu,et al.  Matrix deactivation: A general approach to improve stability of unstable and reactive pharmaceutical genotoxic impurities for trace analysis. , 2010, Journal of pharmaceutical and biomedical analysis.

[13]  Ravi P. Shah,et al.  A critical review on the use of modern sophisticated hyphenated tools in the characterization of impurities and degradation products. , 2012, Journal of pharmaceutical and biomedical analysis.

[14]  M. Andre,et al.  Ionic liquids as advantageous solvents for headspace gas chromatography of compounds with low vapor pressure. , 2005, Analytical chemistry.

[15]  David Q. Liu,et al.  A Systematic Method Development Strategy for Determination of Pharmaceutical Genotoxic Impurities , 2010 .

[16]  David Q. Liu,et al.  A practical derivatization LC/MS approach for determination of trace level alkyl sulfonates and dialkyl sulfates genotoxic impurities in drug substances. , 2008, Journal of pharmaceutical and biomedical analysis.

[17]  Matthew D. Green,et al.  Thermal, rheological, and ion-transport properties of phosphonium-based ionic liquids. , 2011, The journal of physical chemistry. A.

[18]  Andrew Teasdale,et al.  Risk Assessment of Genotoxic Impurities in New Chemical Entities: Strategies To Demonstrate Control , 2013 .

[19]  D. Elder,et al.  Control and analysis of alkyl esters of alkyl and aryl sulfonic acids in novel active pharmaceutical ingredients (APIs). , 2008, Journal of pharmaceutical and biomedical analysis.

[20]  David Q. Liu,et al.  Gas-phase derivatization via the Meerwein reaction for selective and sensitive LC-MS analysis of epoxides in active pharmaceutical ingredients. , 2011, Journal of pharmaceutical and biomedical analysis.

[21]  D. Elder,et al.  Control and analysis of hydrazine, hydrazides and hydrazones--genotoxic impurities in active pharmaceutical ingredients (APIs) and drug products. , 2011, Journal of pharmaceutical and biomedical analysis.

[22]  Joan F. Brennecke,et al.  Thermophysical Properties of Imidazolium-Based Ionic Liquids , 2004 .

[23]  David Q. Liu,et al.  Recent advances in trace analysis of pharmaceutical genotoxic impurities. , 2010, Journal of pharmaceutical and biomedical analysis.

[24]  Jing-fu Liu,et al.  Advances in analytical chemistry using the unique properties of ionic liquids , 2012 .

[25]  H. Niederländer,et al.  A new derivatization reagent for LC-MS/MS screening of potential genotoxic alkylation compounds. , 2013, Journal of pharmaceutical and biomedical analysis.

[26]  Gino Bentivoglio,et al.  Ionic liquids as superior solvents for headspace gas chromatography of residual solvents with very low vapor pressure, relevant for pharmaceutical final dosage forms. , 2009, Journal of chromatography. A.

[27]  N V V S S Raman,et al.  Strategies for the identification, control and determination of genotoxic impurities in drug substances: a pharmaceutical industry perspective. , 2011, Journal of pharmaceutical and biomedical analysis.

[28]  Ye Jiang,et al.  Room temperature ionic liquid as matrix medium for the determination of residual solvents in pharmaceuticals by static headspace gas chromatography. , 2007, Journal of chromatography. A.

[29]  D. Snodin Genotoxic Impurities: A Regulatory Toxicology Commentary on Recent Articles in Organic Process Research & Development , 2011 .

[30]  G. Jenkins,et al.  Do dose response thresholds exist for genotoxic alkylating agents? , 2005, Mutagenesis.

[31]  M. D. Joshi,et al.  Selective extraction of genotoxic impurities and structurally alerting compounds using polymeric ionic liquid sorbent coatings in solid-phase microextraction: Alkyl halides and aromatics. , 2012, Journal of chromatography. A.

[32]  V. Srinivasadesikan,et al.  On the Chemical Stabilities of Ionic Liquids , 2009, Molecules.

[33]  T. Kojima,et al.  Correlation between Electron Capture Response and Chemical Structure for Sulfur Compounds , 1976 .

[34]  Finn Drabløs,et al.  Alkylation damage in DNA and RNA--repair mechanisms and medical significance. , 2004, DNA repair.

[35]  J. Gilman,et al.  Thermal degradation studies of alkyl-imidazolium salts and their application in nanocomposites , 2004 .

[36]  G. Sluggett,et al.  Determination and control of TEMPO, a potentially genotoxic free radical reagent used in the synthesis of filibuvir. , 2012, Journal of pharmaceutical and biomedical analysis.

[37]  T. McGovern,et al.  Regulation of genotoxic and carcinogenic impurities in drug substances and products , 2006 .

[38]  Derek Robinson,et al.  Control of Genotoxic Impurities in Active Pharmaceutical Ingredients: A Review and Perspective , 2010 .